Harrow Stock Plunges on 4Q Earnings Miss, Conservative Outlook

Dow Jones03-04

By Elias Schisgall

Shares of Harrow plunged after the company posted a smaller-than-expected profit in the fourth quarter and said it was changing its approach to guidance, and estimated 2026 revenue below Wall Street expectations.

Shares fell 25% to $40.40 in Tuesday morning trading. The stock is up 58% over the past 12 months.

The biotechnology company late Monday posted a profit of $6.63 million, or 17 cents a share, compared with a profit of $6.78 million, or 24 cents a share, a year earlier.

Revenue rose to $89.1 million, up from $66.8 million a year prior.

Analysts surveyed by FactSet were expecting earnings of 37 cents a share and $90 million in revenue.

For the current year, the company is projecting revenue between $350 million and $365 million. It expects revenue in the first half of the year of between $133 million and $153 million, with revenue estimated at between $203 million and $226 million in the second half.

Analysts are expecting $391.4 million in revenue for the full year.

The company said it was adopting a more conservative approach to guidance in a push to build better structure and transparency for shareholders. "Instead of our guidance 'meeting and beating,' we have too often been in the 'stress and miss' camp. This has not served our stockholders or us well," Chief Executive Mark Baum said in a letter to stockholders.

Write to Elias Schisgall at elias.schisgall@wsj.com

(END) Dow Jones Newswires

March 03, 2026 11:08 ET (16:08 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2616322318?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-04 00:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616322318","market":"fut","top_or_hot":-1,"title":"Harrow Stock Plunges on 4Q Earnings Miss, Conservative Outlook","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Elias Schisgall \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Harrow plunged after the company posted a smaller-than-expected profit in the fourth quarter and said it was changing its approach to guidance, and estimated 2026 revenue below Wall Street expectations. \n</p>\n<p>\n  Shares fell 25% to $40.40 in Tuesday morning trading. The stock is up 58% over the past 12 months. \n</p>\n<p>\n  The biotechnology company late Monday posted a profit of $6.63 million, or 17 cents a share, compared with a profit of $6.78 million, or 24 cents a share, a year earlier. \n</p>\n<p>\n  Revenue rose to $89.1 million, up from $66.8 million a year prior. \n</p>\n<p>\n  Analysts surveyed by FactSet were expecting earnings of 37 cents a share and $90 million in revenue. \n</p>\n<p>\n  For the current year, the company is projecting revenue between $350 million and $365 million. It expects revenue in the first half of the year of between $133 million and $153 million, with revenue estimated at between $203 million and $226 million in the second half. \n</p>\n<p>\n  Analysts are expecting $391.4 million in revenue for the full year. \n</p>\n<p>\n  The company said it was adopting a more conservative approach to guidance in a push to build better structure and transparency for shareholders. \"Instead of our guidance 'meeting and beating,' we have too often been in the 'stress and miss' camp. This has not served our stockholders or us well,\" Chief Executive Mark Baum said in a letter to stockholders. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 03, 2026 11:08 ET (16:08 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Harrow Stock Plunges on 4Q Earnings Miss, Conservative Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHarrow Stock Plunges on 4Q Earnings Miss, Conservative Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-03-04 00:08</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Elias Schisgall \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Harrow plunged after the company posted a smaller-than-expected profit in the fourth quarter and said it was changing its approach to guidance, and estimated 2026 revenue below Wall Street expectations. \n</p>\n<p>\n  Shares fell 25% to $40.40 in Tuesday morning trading. The stock is up 58% over the past 12 months. \n</p>\n<p>\n  The biotechnology company late Monday posted a profit of $6.63 million, or 17 cents a share, compared with a profit of $6.78 million, or 24 cents a share, a year earlier. \n</p>\n<p>\n  Revenue rose to $89.1 million, up from $66.8 million a year prior. \n</p>\n<p>\n  Analysts surveyed by FactSet were expecting earnings of 37 cents a share and $90 million in revenue. \n</p>\n<p>\n  For the current year, the company is projecting revenue between $350 million and $365 million. It expects revenue in the first half of the year of between $133 million and $153 million, with revenue estimated at between $203 million and $226 million in the second half. \n</p>\n<p>\n  Analysts are expecting $391.4 million in revenue for the full year. \n</p>\n<p>\n  The company said it was adopting a more conservative approach to guidance in a push to build better structure and transparency for shareholders. \"Instead of our guidance 'meeting and beating,' we have too often been in the 'stress and miss' camp. This has not served our stockholders or us well,\" Chief Executive Mark Baum said in a letter to stockholders. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 03, 2026 11:08 ET (16:08 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HROW","symbol_name":"Harrow Health Inc","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2616322318","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2616322318","pubTimestamp":1772554080,"columns":[{"name":"Data Report","id":30,"label_key":"dataReport"}],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Harrow plunged after the company posted a smaller-than-expected profit in the fourth quarter and said it was changing its approach to guidance, and estimated 2026 revenue below Wall Street expectations.Shares fell 25% to $40.40 in Tuesday morning trading. The stock is up 58% over the past 12 months.The biotechnology company late Monday posted a profit of $6.63 million, or 17 cents a share, compared with a profit of $6.78 million, or 24 cents a share, a year earlier.Revenue rose to $89.1 million, up from $66.8 million a year prior.Analysts surveyed by FactSet were expecting earnings of 37 cents a share and $90 million in revenue.The company said it was adopting a more conservative approach to guidance in a push to build better structure and transparency for shareholders. \"Instead of our guidance 'meeting and beating,' we have too often been in the 'stress and miss' camp. This has not served our stockholders or us well,\" Chief Executive Mark Baum said in a letter to stockholder","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HROW":"Harrow Health Inc","BK4007":"制药","BK4557":"大麻股"},"translate_title":"哈罗股价因第四季度盈利未达预期而暴跌，前景保守","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HROW":0.9},"content_text":"By Elias Schisgall \n\n\n \n\n\n  Shares of Harrow plunged after the company posted a smaller-than-expected profit in the fourth quarter and said it was changing its approach to guidance, and estimated 2026 revenue below Wall Street expectations. \n\n\n  Shares fell 25% to $40.40 in Tuesday morning trading. The stock is up 58% over the past 12 months. \n\n\n  The biotechnology company late Monday posted a profit of $6.63 million, or 17 cents a share, compared with a profit of $6.78 million, or 24 cents a share, a year earlier. \n\n\n  Revenue rose to $89.1 million, up from $66.8 million a year prior. \n\n\n  Analysts surveyed by FactSet were expecting earnings of 37 cents a share and $90 million in revenue. \n\n\n  For the current year, the company is projecting revenue between $350 million and $365 million. It expects revenue in the first half of the year of between $133 million and $153 million, with revenue estimated at between $203 million and $226 million in the second half. \n\n\n  Analysts are expecting $391.4 million in revenue for the full year. \n\n\n  The company said it was adopting a more conservative approach to guidance in a push to build better structure and transparency for shareholders. \"Instead of our guidance 'meeting and beating,' we have too often been in the 'stress and miss' camp. This has not served our stockholders or us well,\" Chief Executive Mark Baum said in a letter to stockholders. \n\n\n \n\n\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 03, 2026 11:08 ET (16:08 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2616322318","isCrawlerRequest":true}